Free Trial

Biotricity Q3 2024 Earnings Report

Biotricity logo
$0.28 -0.01 (-4.08%)
(As of 12/20/2024 05:55 PM ET)

Biotricity EPS Results

Actual EPS
-$0.34
Consensus EPS
-$0.41
Beat/Miss
Beat by +$0.07
One Year Ago EPS
N/A

Biotricity Revenue Results

Actual Revenue
$2.97 million
Expected Revenue
$3.00 million
Beat/Miss
Missed by -$30.00 thousand
YoY Revenue Growth
N/A

Biotricity Announcement Details

Quarter
Q3 2024
Time
N/A
Could This Tiny Device Help You Make an Extra $30k a Year? (Ad)

I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.

Click here to see the details because I believe a lot of people will get rich.

Biotricity Earnings Headlines

⭕ [URGENT] Buy Alert just triggered
My absolute favorite stock just hit a critical "buy now" trigger price.
Biotricity Inc BTCY
See More Biotricity Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Biotricity? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Biotricity and other key companies, straight to your email.

About Biotricity

Biotricity (OTCMKTS:BTCY), a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

View Biotricity Profile

More Earnings Resources from MarketBeat

Upcoming Earnings